NRx Pharmaceuticals Receives Patent for Neuropsychiatric Treatments - MyChesCo
RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) announced that the U.S. Patent and Trademark Office recently issued U.S. Patent No. 11,576,911. This patent, issued to Glytech LLC, is exclusively …
MyChesCo
